Effect of arotinolol on chronic heart failure: A systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Heart failure is the end stage of all cardiovascular diseases, which brings a heavy burden to the global health network. Arotinolol, as a new type of β Receptor blocker, has a good antihypertensive effect. Many clinical trials have observed the clinical efficacy of arotinolol in the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Pingping, Song, Qingya, Wang, Yifei, Wang, Anzhu, Guo, Lijun, Zhang, Hongwei, Zhang, Zhibo, Ma, Xiaochang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795060/
https://www.ncbi.nlm.nih.gov/pubmed/36588575
http://dx.doi.org/10.3389/fcvm.2022.1071387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795060/
https://www.ncbi.nlm.nih.gov/pubmed/36588575
http://dx.doi.org/10.3389/fcvm.2022.1071387

Ejemplares similares